SoftOx Solutions Investor Relations Material
Latest events
Investor Update
SoftOx Solutions
Q1 2025
27 Jun, 2025
Q4 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SoftOx Solutions
Access all reports
SoftOx Solutions operates as a biotech company. The company focuses on the development of medical devices for diagnostics and treatment of tissue injury and other diseases. Its products include SoftOx Endo, which is used to treat tissue deterioration in the esophagus; and SoftOx Burn, which is used to prevent scarring following burn injuries.
Key slides for SoftOx Solutions
Investor Update
SoftOx Solutions
Investor Update
SoftOx Solutions
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SOFTX
Country
🇳🇴 Norway